Drug
Verducatib clinical trials
Also written BI 1291583.
- studies test it
- 18
- open now
- 4
- in phase 3
- 1
- first study started
- 2018
Keep track of what changes. Save the verducatib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
18 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 14
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 18 · Other 0
Often tested with
Tested in the same studies.
Erythromycin (1) · Itraconazole (1) · Carbamazepine (1) · Moxifloxacin (1)
Studies
Open first, then newest update. How each study uses verducatib is read from its arms, and is right about nine times in ten.
Testing it · 18
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With BronchiectasisRecruitingPhase 3Boehringer IngelheimNCT06872892Written as BI 1291583
- A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver ProblemsRecruitingPhase 1Boehringer IngelheimNCT07023354Written as BI 1291583
- A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the BloodRecruitingPhase 1Boehringer IngelheimNCT07781631Written as Verducatib
- A Study in Healthy People to Measure How Different Doses of Verducatib Affect the HeartRecruitingPhase 1Boehringer IngelheimNCT07760246Written as Verducatib
- Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This MedicineActive, not recruitingPhase 2Boehringer IngelheimNCT05846230Written as BI 1291583
- A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese ParticipantsCompletedPhase 1Boehringer IngelheimNCT07531628Written as Verducatib
- A Study to Test Whether Different Doses of BI 1291583 Help People With BronchiectasisCompletedPhase 2Boehringer IngelheimNCT05238675Written as BI 1291583
- A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)CompletedPhase 2Boehringer IngelheimNCT05865886Written as BI 1291583
- A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the BloodCompletedPhase 1Boehringer IngelheimNCT06917872Written as BI 1291583
- A Study in Healthy Men to Test How BI 1291583 is Taken up by the BodyCompletedPhase 1Boehringer IngelheimNCT06166992Written as BI 1291583
- A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are ToleratedCompletedPhase 1Boehringer IngelheimNCT04866160Written as BI 1291583
- A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different FormulationsCompletedPhase 1Boehringer IngelheimNCT06631417Written as BI 1291583
- A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy MenCompletedPhase 1Boehringer IngelheimNCT03837964Written as BI 1291583
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1291583 in the BloodCompletedPhase 1Boehringer IngelheimNCT03890887Written as BI 1291583
- A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are ToleratedCompletedPhase 1Boehringer IngelheimNCT05183347Written as BI 1291583
- A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the BodyCompletedPhase 1Boehringer IngelheimNCT06791187Written as BI 1291583
- A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are ToleratedTerminatedPhase 1Boehringer IngelheimNCT03868540Written as BI 1291583
- This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are ToleratedTerminatedPhase 1Boehringer IngelheimNCT03414008Written as BI 1291583
Codes
What other systems call verducatib · ClinicalTrials.gg INT017202
- UNII (FDA) LPO8EV0QNSVERDUCATIBConfirmed FDA, Wikidata
- Wikidata Q140529364verducatibConfirmed FDA, Wikidata
- NCI Thesaurus C215781VerducatibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LPO8EV0QNS | VERDUCATIB | Confirmed FDA, Wikidata |
| Wikidata | Q140529364 | verducatib | Confirmed FDA, Wikidata |
| NCI Thesaurus | C215781 | Verducatib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.